These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 35697170)

  • 1. Intrahepatic cholangiocarcinoma: typical features, uncommon variants, and controversial related entities.
    Zen Y
    Hum Pathol; 2023 Feb; 132():197-207. PubMed ID: 35697170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An immunostaining panel of C-reactive protein, N-cadherin, and S100 calcium binding protein P is useful for intrahepatic cholangiocarcinoma subtyping.
    Akita M; Sawada R; Komatsu M; Suleman N; Itoh T; Ajiki T; Heaton N; Fukumoto T; Zen Y
    Hum Pathol; 2021 Mar; 109():45-52. PubMed ID: 33321161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-to-Date Pathologic Classification and Molecular Characteristics of Intrahepatic Cholangiocarcinoma.
    Chung T; Park YN
    Front Med (Lausanne); 2022; 9():857140. PubMed ID: 35433771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NIPBL::NACC1 Fusion Hepatic Carcinoma.
    Hissong E; Al Assaad M; Bal M; Reed KA; Fornelli A; Levine MF; Gundem G; Semaan A; Orr CE; Sakhadeo U; Manohar J; Sigouros M; Wilkes D; Sboner A; Montgomery EA; Graham RP; Medina-Martínez JS; Robine N; Fang JM; Choi EK; Westerhoff M; Delgado-de la Mora J; Caudell P; Yantiss RK; Papaemmanuil E; Elemento O; Sigel C; Jessurun J; Mosquera JM
    Am J Surg Pathol; 2024 Feb; 48(2):183-193. PubMed ID: 38047392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological characterization of so-called "cholangiocarcinoma with intraductal papillary growth" with respect to "intraductal papillary neoplasm of bile duct (IPNB)".
    Nakanuma Y; Sato Y; Ojima H; Kanai Y; Aishima S; Yamamoto M; Ariizumi S; Furukawa T; Hayashi H; Unno M; Ohta T;
    Int J Clin Exp Pathol; 2014; 7(6):3112-22. PubMed ID: 25031730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel NIPBL-NACC1 Gene Fusion Is Characteristic of the Cholangioblastic Variant of Intrahepatic Cholangiocarcinoma.
    Argani P; Palsgrove DN; Anders RA; Smith SC; Saoud C; Kwon R; Voltaggio L; Assarzadegan N; Oshima K; Rooper L; Matoso A; Zhang L; Cantarel BL; Gagan J; Antonescu CR
    Am J Surg Pathol; 2021 Nov; 45(11):1550-1560. PubMed ID: 33999553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is nestin a diagnostic marker for combined hepatocellular-cholangiocarcinoma?
    Sasaki M; Sato Y; Nakanuma Y
    Histopathology; 2022 Apr; 80(5):859-868. PubMed ID: 35076959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular diagnosis of intrahepatic cholangiocarcinoma.
    Haga H; Patel T
    J Hepatobiliary Pancreat Sci; 2015 Feb; 22(2):114-23. PubMed ID: 25267595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of small duct- and large duct-type intrahepatic cholangiocarcinoma.
    Kinzler MN; Schulze F; Jeroch J; Schmitt C; Ebner S; Gretser S; Bein J; Finkelmeier F; Trojan J; Zeuzem S; Schnitzbauer AA; Demes MC; Reis H; Wild PJ; Walter D
    Histopathology; 2024 May; 84(6):1061-1067. PubMed ID: 38409827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features.
    Liau JY; Tsai JH; Yuan RH; Chang CN; Lee HJ; Jeng YM
    Mod Pathol; 2014 Aug; 27(8):1163-73. PubMed ID: 24406866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histological and molecular characterization of intrahepatic bile duct cancers suggests an expanded definition of perihilar cholangiocarcinoma.
    Akita M; Sofue K; Fujikura K; Otani K; Itoh T; Ajiki T; Fukumoto T; Zen Y
    HPB (Oxford); 2019 Feb; 21(2):226-234. PubMed ID: 30170977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis and classification of intrahepatic cholangiocarcinoma: different characters of perihilar large duct type versus peripheral small duct type.
    Aishima S; Oda Y
    J Hepatobiliary Pancreat Sci; 2015 Feb; 22(2):94-100. PubMed ID: 25181580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bile duct adenoma and small-sized small duct type intrahepatic cholangiocarcinoma show distinct differences in genetic alterations, expression of IMP3 and EZH2 and stromal and inflammatory components.
    Sasaki M; Sato Y; Nakanuma Y
    Histopathology; 2023 Aug; 83(2):298-309. PubMed ID: 37140546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances in Pathology of Intrahepatic Cholangiocarcinoma.
    Choi JH; Thung SN
    Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibin-Positive "Cholangioblastic" Variant of Intrahepatic Cholangiocarcinoma: Report of 3 New Patients With Review of the Literature.
    Bakhshwin A; Lai KK; Ammoun A; Friedman K; El Hag M
    Int J Surg Pathol; 2023 Dec; 31(8):1495-1504. PubMed ID: 37073447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical interpretation of the WHO subclassification of intrahepatic cholangiocarcinoma: a narrative review.
    Akita M; Yanagimoto H; Tsugawa D; Zen Y; Fukumoto T
    Surg Today; 2024 Apr; ():. PubMed ID: 38563999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile duct adenoma may be a precursor lesion of small duct type intrahepatic cholangiocarcinoma.
    Sasaki M; Sato Y; Nakanuma Y
    Histopathology; 2021 Jan; 78(2):310-320. PubMed ID: 33405289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrahepatic cholangiocarcinoma: Tumour heterogeneity and its clinical relevance.
    Komuta M
    Clin Mol Hepatol; 2022 Jul; 28(3):396-407. PubMed ID: 35032970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nestin may be a candidate marker for differential diagnosis between small duct type and large duct type intrahepatic cholangiocarcinomas.
    Sasaki M; Sato Y; Nakanuma Y
    Pathol Res Pract; 2024 Jan; 253():155061. PubMed ID: 38154357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic upregulation of TET2 is an independent poor prognostic factor for intrahepatic cholangiocarcinoma.
    Yamashita H; Tourna A; Akita M; Itoh T; Chokshi S; Ajiki T; Fukumoto T; Youngson NA; Zen Y
    Virchows Arch; 2022 May; 480(5):1077-1085. PubMed ID: 34905094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.